Home NDC 76189-113 Alunbrig
Product NDC 76189-113
11-digit product format 761890113
Labeler code 76189
Product ID 76189-113_76928450-348f-4d49-b086-17866cfb34c6
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Brigatinib
Dosage form TABLET, COATED
Route ORAL
Labeler ARIAD Pharmaceuticals Inc.
Application NDA208772
Marketing category NDA
Marketing start 2017-04-28
Marketing end 2020-12-12
Substance BRIGATINIB
Active strength 30 mg/1
Pharmacologic classes Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record
Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N208772-001 ALUNBRIG BRIGATINIB 30MG TABLET / ORAL RLD 2017-04-28 N208772-002 ALUNBRIG BRIGATINIB 90MG TABLET / ORAL RLD, RS 2017-04-28 N208772-003 ALUNBRIG BRIGATINIB 180MG TABLET / ORAL RLD 2017-10-02
Orange Book patents# Current patent rows page 1 of 1 · 12 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N208772-001 9273077 2029-05-21 U-2837 2017-05-26 N208772-001 9012462 2031-04-28 Drug substance 2017-05-26 N208772-001 9611283 2034-04-10 U-2837 2017-05-26 N208772-001 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 N208772-002 9273077 2029-05-21 U-2837 2017-05-26 N208772-002 9012462 2031-04-28 Drug substance 2017-05-26 N208772-002 9611283 2034-04-10 U-2837 2017-05-26 N208772-002 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 N208772-003 9273077 2029-05-21 U-2837 2017-10-23 N208772-003 9012462 2031-04-28 Drug substance 2017-10-23 N208772-003 9611283 2034-04-10 U-2837 2017-10-23 N208772-003 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 3 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N208772-001 ODE-300 2027-05-22 N208772-002 ODE-300 2027-05-22 N208772-003 ODE-300 2027-05-22
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 129 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD, RS 2017-04-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD 2017-10-02 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD, RS 2017-04-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD 2017-10-02 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD, RS 2017-04-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD 2017-10-02 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208772-002 ALUNBRIG 90MG TABLET / ORAL RLD 2017-04-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N208772-003 ALUNBRIG 180MG TABLET / ORAL RLD, RS 2017-10-02 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N208772-001 ALUNBRIG 30MG TABLET / ORAL RLD 2017-04-28 301d65b070ca…
Observed Orange Book patent history# Patent history page 1 of 13 · 513 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-09-14 22:38:34 2026-08 N208772-001 9273077 2029-05-21 U-2837 2017-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-001 9012462 2031-04-28 Drug substance 2017-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-001 9611283 2034-04-10 U-2837 2017-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-001 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-002 9273077 2029-05-21 U-2837 2017-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-002 9012462 2031-04-28 Drug substance 2017-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-002 9611283 2034-04-10 U-2837 2017-05-26 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-002 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-003 9273077 2029-05-21 U-2837 2017-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-003 9012462 2031-04-28 Drug substance 2017-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-003 9611283 2034-04-10 U-2837 2017-10-23 84e616aacf4f…2026-09-14 22:38:34 2026-08 N208772-003 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 N208772-001 9273077 2029-05-21 U-2837 2017-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-001 9012462 2031-04-28 Drug substance 2017-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-001 9611283 2034-04-10 U-2837 2017-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-001 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-002 9273077 2029-05-21 U-2837 2017-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-002 9012462 2031-04-28 Drug substance 2017-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-002 9611283 2034-04-10 U-2837 2017-05-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-002 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-003 9273077 2029-05-21 U-2837 2017-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-003 9012462 2031-04-28 Drug substance 2017-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-003 9611283 2034-04-10 U-2837 2017-10-23 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N208772-003 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N208772-001 9273077 2029-05-21 U-2837 2017-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-001 9012462 2031-04-28 Drug substance 2017-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-001 9611283 2034-04-10 U-2837 2017-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-001 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-002 9273077 2029-05-21 U-2837 2017-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-002 9012462 2031-04-28 Drug substance 2017-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-002 9611283 2034-04-10 U-2837 2017-05-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-002 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-003 9273077 2029-05-21 U-2837 2017-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-003 9012462 2031-04-28 Drug substance 2017-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-003 9611283 2034-04-10 U-2837 2017-10-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N208772-003 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-001 9273077 2029-05-21 U-2837 2017-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-001 9012462 2031-04-28 Drug substance 2017-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-001 9611283 2034-04-10 U-2837 2017-05-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N208772-001 10385078 2035-11-10 U-2837 Drug substance, Drug product 2019-09-10 31067a03dcf5…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 9 · 330 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Alunbrig BRIGATINIB Takeda Pharmaceuticals America, Inc. 0fe9ff20-d402-41f3-bc1e-7002ea7007db 2026-01-12 Warnings, Adverse reactions Exact identifier application applno (NDA): 208772 application number: NDA208772